Investigation of C-peptide Index for Carbo70 by the severity of diabetic state by Ebe, Koji et al.
Volume 2 • Issue 2 • 1000113Clin Med Case Rep, an open access journal
Ebe et al., Clin Med Case Rep 2018, 2:2
Research Article Open Access
Clinical and Medical Case ReportsClinic
al
 an
d M
edical Case Reports
*Corresponding author: Hiroshi Bando, Tokushima University /Medical Research, 
Tokushima, Japan, Tel: +81-90-3187-2485; E-mail: pianomed@bronze.ocn.ne.jp
Received June 08, 2018; Accepted July 09, 2018; Published July 16, 2018
Citation: Ebe K, Bando H, Muneta T, Bando M, Yonei Y (2018) Investigation of 
C-peptide Index for Carbo70 by the severity of diabetic state. Clin Med Case Rep 
2: 113. 
Copyright: © 2018 Ebe K, et al. This is an open-access article distributed under 
the terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author and 
source are credited.
Investigation of C-peptide Index for Carbo70 by the severity of diabetic 
state
Koji Ebe1,2, Hiroshi Bando2,3*, Tetsuo Muneta2,4, Masahiro Bando5, Yoshikazu Yonei6 
1Takao Hospital, Kyoto, Japan 
2Japan Low Carbohydrate Diet Promotion Association, Kyoto, Japan 
3Tokushima University / Medical Research, Tokushima, Japan 
4Muneta Maternity Clinic, Chiba, Japan
5Department of Nutrition and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
6Anti-Aging Medical Research Center, Graduate School of Life and Medical Sciences, Doshisha University, Kyoto, Japan
Abstract
Background: Authors and colleagues have reported nutritional research so far concerning Low Carbohydrate 
Diet (LCD). Formerly, we proposed useful method for insulin response to 70 g of carbohydrate. Similarly, C-peptide 
index for Carbohydrate-70 (CPI-Carbo70) is studied and proposed in this report.
Subjects and Methods: Subjects enrolled were diabetic patients that were divided into three groups due to 
diabetic severity. Among them, average HbA1c was 6.6%, 7.8%, 10.0% in low, middle, high group, n=15, 15, 16 
respectively. As in-patients, they were on Calorie Restriction meal on day 1 and 2, which has 1400kcal/day with 
carbohydrates 60%, lipids 25%, protein 15%. On day 2, breakfast with carbohydrate 70 g was provided, and glucose 
and C-peptide levels were measured at 0, 30 minutes. 
Results: Biomarkers were analyzed in 3 groups. Increment C-peptide (CP) and CPI-Carbo70 in 3 groups were 
0.58, 0.57, 0.27 and 2.1, 3.2, 1.2, respectively. As for M value, CP increment, CP on 30 min, CPI-Carbo70 was 
investigated, which were lower in high group. There is significant correlation between HbA1c and CPI-Carbo70 
(p<0.05). 
Discussion and Conclusion: CPI-Carbo70 may be useful for evaluating pancreas function and glucose 
variability. These data could be basal and useful in the light of clinical evaluation and further research development.
Keywords: C-peptide index for Carbohydrate-70 (CPI-Carbo70); 
Insulinogenic index (IGI); Calorie Restriction (CR); C-peptide (CP); 
Type 2 diabetes mellitus (T2DM)
Introduction 
Metabolic syndrome (Met-S) has been increasing and become 
the important problem in developed and also developing countries 
[1]. It includes several influencing factors such as lifestyle, age, meal, 
exercise, habitual status, socioeconomic status, and others [2]. From 
pathophysiological aspect, Met-S has basically insulin resistance and 
close relationship of developing diabetic status with macroangiopathy 
and microangiopathy [3]. 
The number of diabetic patients in almost region of the world has 
been increased [4]. As to diabetic practice, there has been recently 
a large paradigm changes. The proposal of change in standard value 
about HbA1c was presented by American College of Physicians (ACP) 
[5]. The important point for the primary care physicians was that the 
management goal for HbA1c in most type 2 diabetic patients would be 
7% or more and less than 8%. In response to this statement, American 
Diabetes Association (ADA) showed the comments concerning 
the goals and treatment for diabetes associated with complications 
of cardiovascular disease and the prevention of recurrence in the 
treatment for diabetes [6]. 
Furthermore, there is “The Prospective Urban Rural Epidemiology 
(PURE) study”, which is known as multi-centered epidemiological 
study. It has covered large-scale area with 18 countries worldwide [7]. It 
showed that total mortality risk was increased with increased intake of 
carbohydrate (HR 1.28). Then, carbohydrate was recommended to be 
reduced for healthy daily living [8].
A standard of Medical Care about Diabetes was proposed recently, 
by International Diabetes Federation (IDF) [9]. Among them, 
important aspects were checking intake and counting for carbohydrate 
amount with experience-based evaluation. Study of macronutrient and 
eating methods may be useful for better glucose control.
On contrast, various discussions on diabetic nutritional therapy 
have been continued, mainly Low Carbohydrate Diet (LCD) and CR 
[10-12]. LCD was started by Atkins and others in North American and 
European region and was developed widely [13]. Similarly, The author 
started LCD in Japan, and have treated and reported about its clinical 
effects [14]. In addition, we have proposed useful and simple formula 
diet of LCD, with elevated ketone bodies, renal function, hyperlipidemia 
and M value [15-17]. 
Through our consecutive investigation concerning CR and LCD, 
we proposed new index that is simple and useful method. Similar to 
75 g oral glucose tolerance test (75 g OGTT) and insulinogenic index 
(IGI) to carbohydrate 75 g, we came to take advantage of breakfast of 
CR including 70 g of carbohydrate. Corresponding to IGI-75 g OGTT, 
IGI-Carbo70 was proposed and its clinical usefulness was investigated 
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[18]. Along to this research direction, c-peptide index at 0-30 minutes 
for Carbo70 was studied in this study.
Subjects and Methods
Enrolled subjects were type 2 diabetes mellitus (T2DM) and were 
divided into three groups due to the severity of the diabetic state. Three 
groups were called low, middle, high group, associated with the data 
that average HbA1c value was 6.6%, 7.8%, 10.0%, and number of the 
cases was 15, 15, 16, respectively.
Methods are performed in the hospital. Diabetic cases were 
admitted for 2 weeks for detail evaluation treatment. They were on our 
protocol of CR and LCD nutritional therapy as in-patient. The details of 
the methods are described as follows: 1) CR diet was given to diabetic 
patients on day 1-2. CR had 1400 kcal/day and its PFC was 15%, 25%, 
60%, respectively. 2) LCD was given on day 3-14, including 1400 kcal/
day with the PFC=24%, 64%, 12%, respectively. 
As mentioned above, both protocol with CR and LCD was continued 
for years in our clinical research. In current study, however, we have 
used only the breakfast on day 2. CR meal includes 840 kcal a day from 
carbohydrate including totally the mount of carbohydrate 210g in three 
meals. It is from the nutrients balance of PFC by the standard guideline 
for Japan, which is proposed from Japan Diabetes Society (JDS) [19]. 
In this way, formula breakfast meal has provided to the subjects after 
overnight fasting, which contains carbohydrate 70 g in it.
The precise protocol of the study is in the following: 1) fundamental 
biomarkers were checked in early morning on day 2, 2) Blood levels 
of glucose and C-peptide were measured before breakfast (0 min), 
3) patient eats breakfast including carbohydrate 70 g, 4) glucose and 
C-peptide were measured 30 minutes after breakfast, 5) values of 0 
min, 30 min and increased value of blood glucose and C-peptide were 
measured, 6) index of ratio for increased value (increment) of C-peptide 
/ glucose was investigated and analyzed, which is CPI-Carbo70.
Profile of blood glucose and Morbus value
Regarding profile of blood glucose on day 2 was checked 7 times 
a day, that is, 8, 10, 12, 14, 17, 19, 22 h. From these, we calculated the 
blood glucose in average and M value. 
M value has been known as the useful index indicating two factors, 
which are blood glucose value and the mean amplitude of glycemic 
excursions (MAGE) [20,21]. After obtaining the data of profile of 
glucose, we can calculate glucose level in average and M value. M 
value was proposed for researching the status of MAGE. This index is 
characteristic for a logarithmic transformation of the deviation of blood 
glucose from an arbitrary assigned “ideal” glucose value. It includes the 
degree of mean glucose value and glucose swings [20-22].
The definition of M value is shown. 1) M=MBS + MW: M value is the 
total of MBS and MW. 2) MW is maximum blood glucose − minimum 
glucose)/20. 3) MBS is the mean of MBSBS. 4) MBSBS is the individual 
M-value for each blood glucose value, that is calculated as (absolute 
value of [10 × log (blood glucose level/120)])3 [20-22].
For M value, the interpretation would be in the following. 1) Less 
than 180 is normal or standard, 2) the range between 180 to 320 is 
borderline, 3) more than 320 are abnormal. As several experimental 
researches, similar results were obtained on 7 times or 20 times per day 
[21-23]. These results revealed almost similar, when it is compared with 
that of continuous glucose monitoring (CGM) [21,22,24].
Statistical analysis
The results of this study were revealed by 2 ways. One is represented 
by the mean ± standard deviation (SD), and another is by the median, 
quartile of 25% and 75% according to the biomarkers. For the 
investigating the results statistically, we used the correlation coefficients 
which were calculated according to the Spearman test. The reference 
method was used on the analytical standard tool [25].
Ethical standard
This research was conducted in compliance with the ethical 
principles based upon the Declaration of Helsinki, where additional 
commentary was done in 2004 General Assembly Tokyo, Japan. It 
was also conducted with Personal Information Protection Law and 
in reference to “Standards for the Implementation of Clinical Trials 
(GCP), an ordinance of the Ministry of Health, Labour and Welfare No. 
28 of March 27, 1997, as well as “Ethical Guidelines for Epidemiology 
Research” by the Ministry of Education, Culture, Sports, Science and 
Technology and the Ministry of Health, Labour and Welfare.
Furthermore, we have established an ethical committee including 
doctor, nurse, pharmacist and expert in the medical and legal specialty. 
We have discussed and made confirmation that current study is 
valid and agreed with all members without any problems. Moreover, 
informed consents and written paper agreements have been obtained 
from the subjects. Current study was also registered in the open 
database (UMIN) run by National University Hospital Council of Japan 
(Test ID: #R000031211).
Results
1. Basal data
In 3 groups, basal data were summarized in Table 1, in which each 
value is shown by average and standard deviation. Average glucose and 
Morbus (M) value in 3 groups was 168 mg/dL, 197 mg/dL, 243 mg/dL, 
and 82, 124, 329, respectively. 
2. C-peptide index for Carbo70
Responses of biomarkers for C-peptide index for Carbo70 are 
summarized in Table 1, in which each value is shown by average and 
standard deviation. Increment of C-peptide in 3 groups was 0.58, 0.57 
and 0.27, respectively. 
3. Comparison of biomarkers in 3 groups
As to the comparison of 3 groups, HbA1c level and average blood 
glucose level are shown in Figure 1. Median value increased in the 
order of group 1,2,3. Similarly, M value in 3 groups showed rather larger 
differences than those of HbA1c and average blood glucose (Figure 2). 
In 3 groups, CP increment from 0 to 30 min and CP level at 30 min 
are shown in Figure 3. High group indicated lower median value than 
others in both. Figure 4 showed C-peptide index for Carbo70 in 3 
Group 1 Group 2 Group 3
Subjects
Number (M/F) 15 (7/8) 15 (9/6) 16 (3/13)
Age(Years old) 62.0 ± 12.2 61.7 ± 11.4 63.9 ± 10.1
Glucose Profile
HbA1c(%) 6.6 ± 0.5 7.8 ± 03 10.0 ± 1.5
Average glucose (md/dL) 168 ± 42.5 197 ± 34.3 243 ± 89.9
Morbus value 82.1 ± 93.2 124  ± 78.1 329  ± 342
Table 1: Subject and basal data.
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groups. The median value was about 0.4 in low and middle groups, and 
about 0.2 in high group.
4. Correlation among CPI-Carbo70, HbA1c and M value
There is significant correlation between CPI-Carbo70 and HbA1c 
(p<0.05) (Figure 5). The statistical precise data were that r=-0.382, 
p=0.010, n=46. Then it is nearly close to p< 0.01. 
On the other hand, there is no significant correlation between 
CPI-Carbo70 and M value (Figure 6). The statistical precise data were 
r=0.274, p=0.065 and n=46. As p value is 0.065, it is very close to 0.05. 
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Figure 1: HbA1c and blood glucose levels in 3 groups.
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Figure 2: Morbus (M) value in low, middle and high groups.
Figure 3: CP increment and CP level at 30 min in 3 groups.
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Discussion
In the clinical practice, the responses of IRI and CPR against 75 
gOGTT have been used for long [26]. Examination of 75 gOGTT was 
performed to 525 persons and blood sugar was measured in detail 
[27]. Half of 262 people were monophasic peaks of blood glucose, with 
the peaks of IRI, C-peptide (CP) at 1-1.5 hours. 0 - 30 minutes of CP 
increased from 0.75 to 2 nmol / L. There was a follow up study with 
prediabetes patients (n=406) for 9 years [28]. As a result, subjects with 
a 30 min post-load glucose ≥ 165 mg/dL and a 30-min C-peptide < 
5 ng/mL showed 8.83 times greater risk of developing diabetes than 
other subjects. People in Asia can decrease the degree of postprandial 
hyperglycemic state from ingestion of rice, by the intake of mixture 
macronutrients of protein, fat and carbohydrate [29].
There are study of difference of glucose, sucrose and honey. In 
diabetics, the increase in the level of C-peptide after honey was not 
significant in comparison with either glucose or sucrose [30]. One of 
the interesting study is about famous Japanese fast food. The meal is 
a rice bowl topped with beef, and it was provided to healthy subjects 
with the investigation of postprandial hyperglycemia [31]. It includes 
protein 18.4 g, fat 20.9 g and carbohydrate 82.9 g, and glucose was 
elevated 65 mg/dL during 0-30 min. 
From these reports, loading exam of glucose 75g and also meals for 
increasing glucose and CP would be useful in the clinical setting. 
There have been several reports concerning postprandial 
hyperglycemia. The continued dietary guidance to eat vegetables before 
staple foods has led to the decrease of HbA1c in patients with diabetes 
and the prevention of the progression of diabetic complications [32]. 
In order to inhibit a postprandial hyperglycemia, it is recommended to 
add dietary fibers before taking noodles and carbohydrate food [33]. 
Furthermore, it has been reported that vinegar and olive oil have an 
inhibitory action on postprandial hyperglycemic states [34]. 
According to the result of a meta-analysis, dietary habit of eating a 
portion of yogurt everyday reduces the risk of T2DM [35]. Therefore, the 
dietary habit to continuously eat yogurt together with a meal possibly 
alleviates glycative stress by inhibiting a postprandial hyperglycemic 
state and contributes to the prevention of aging and the progression of 
age-related diseases [36]. 
There are many different meal habits worldwide. Especially, Asian 
people often take large amount of rice and crops as a starchy food. 
It tends to induce a rapid postprandial hyperglycemic state [37]. 
Furthermore, successive response of insulin surge would cause the 
onset of diabetes [38]. As a result, the number of diabetic patients is 
increasing including 73 million in India and 110 million in China [4]. 
Under such circumstances, scrutiny for diabetes and 1st, 2nd, and 3rd 
prevention are important, and it is possible that CPI-Carbo70 of this 
study can be used in clinical setting.
In this study, the subjects were divided into 3 groups, with obvious 
differences in HbA1c, mean blood glucose and M value. There was 
no obvious difference in blood glucose rise in 3 groups. The degree of 
increase in CP was about half in the high group compared to middle 
and low groups. In the median value, it was 0.4 ng / mL in the low 
and middle groups and 0.2 ng / mL in the high group. On contrast, CP 
value on 30 min was decreased in the order of low, middle, high in the 
3 groups. From the above, the difference in the result value between 
the low and middle groups seemed to be not so remarkable, while the 
reactivity of CP in the high group seemed to show low tendency in 
comparison with those of other 2 groups. 
There was a significant correlation between elevated blood glucose 
and elevated CP at 0-30 minutes. Although the differences were not 
obvious in the three groups, the correlation between rise value in blood 
glucose and CP elevation was strong in each case. This suggests the 
significance and usefulness of our protocol including carbohydrate 
burden doses and serum concentration of CP on 3 and 30 minutes.
In addition, a significant negative correlation (r =- 0.38, p<0.01) 
was observed between HbA1c value and CP Index for Carbo 70. As 
HbA1c value increased, CP index for Carbo70 decreased. These results 
suggest that CP-index for Carbo70 would be useful marker and would 
become the basic data for future development of this area. As the 
correlation between M value and CP Index for Carbo70, r=-0.274 and 
Figure 5: Correlations between CPI-Carbo70 and HbA1c. Significant 
correlation with r= -0.382, p=0.010.
Figure 6: Correlation between CPI-Carbo70 and M value 
                No significant correlation with r= -0.274, p= 0.065.  
Figure 4: C-peptide index for Carbo70 in 3 groups.
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p=0.065 were found, where the relation is nearly p<0.05, and future 
investigation with more cases would be planned.  
Regarding the significance of CP Index for Carbo70, there are 
some limitation concerning the various mixtures of nutrients of meal, 
different ingestion speed of the subject and unstable responses of insulin 
and C-peptide secretion. However, CP Index for Carbo70 would be one 
of the ideas for medical diabetic practice and research.
Conclusion
In summary, response of blood glucose and CP for carbohydrate 
70 g was investigated and C-peptide Index for Carbo70 (CPI-Carbo70) 
was proposed. This new way may be one simple and useful for 
evaluating pancreas function and glucose variability. Current report 
would become one of the basal data in this clinical research leading to 
future development. 
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